
Merck & Co Inc
NYSE:MRK

Merck & Co Inc?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
83.01
131.0275
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Merck & Co Inc hold over its rivals?
What risks and challenges
does Merck & Co Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Merck & Co Inc.
Provide an overview of the primary business activities
of Merck & Co Inc.
What unique competitive advantages
does Merck & Co Inc hold over its rivals?
What risks and challenges
does Merck & Co Inc face in the near future?
Has there been any significant insider trading activity
in Merck & Co Inc recently?
Summarize the latest earnings call
of Merck & Co Inc.
What significant events have occurred
in Merck & Co Inc over the past months?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Merck & Co Inc.
Provide P/S
for Merck & Co Inc.
Provide P/E
for Merck & Co Inc.
Provide P/OCF
for Merck & Co Inc.
Provide P/FCFE
for Merck & Co Inc.
Provide P/B
for Merck & Co Inc.
Provide EV/S
for Merck & Co Inc.
Provide EV/GP
for Merck & Co Inc.
Provide EV/EBITDA
for Merck & Co Inc.
Provide EV/EBIT
for Merck & Co Inc.
Provide EV/OCF
for Merck & Co Inc.
Provide EV/FCFF
for Merck & Co Inc.
Provide EV/IC
for Merck & Co Inc.
Show me price targets
for Merck & Co Inc made by professional analysts.
What are the Revenue projections
for Merck & Co Inc?
How accurate were the past Revenue estimates
for Merck & Co Inc?
What are the Net Income projections
for Merck & Co Inc?
How accurate were the past Net Income estimates
for Merck & Co Inc?
What are the EPS projections
for Merck & Co Inc?
How accurate were the past EPS estimates
for Merck & Co Inc?
What are the EBIT projections
for Merck & Co Inc?
How accurate were the past EBIT estimates
for Merck & Co Inc?
Compare the revenue forecasts
for Merck & Co Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Merck & Co Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Merck & Co Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of Merck & Co Inc compared to its peers.
Compare the P/E ratios
of Merck & Co Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing Merck & Co Inc with its peers.
Analyze the financial leverage
of Merck & Co Inc compared to its main competitors.
Show all profitability ratios
for Merck & Co Inc.
Provide ROE
for Merck & Co Inc.
Provide ROA
for Merck & Co Inc.
Provide ROIC
for Merck & Co Inc.
Provide ROCE
for Merck & Co Inc.
Provide Gross Margin
for Merck & Co Inc.
Provide Operating Margin
for Merck & Co Inc.
Provide Net Margin
for Merck & Co Inc.
Provide FCF Margin
for Merck & Co Inc.
Show all solvency ratios
for Merck & Co Inc.
Provide D/E Ratio
for Merck & Co Inc.
Provide D/A Ratio
for Merck & Co Inc.
Provide Interest Coverage Ratio
for Merck & Co Inc.
Provide Altman Z-Score Ratio
for Merck & Co Inc.
Provide Quick Ratio
for Merck & Co Inc.
Provide Current Ratio
for Merck & Co Inc.
Provide Cash Ratio
for Merck & Co Inc.
What is the historical Revenue growth
over the last 5 years for Merck & Co Inc?
What is the historical Net Income growth
over the last 5 years for Merck & Co Inc?
What is the current Free Cash Flow
of Merck & Co Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for Merck & Co Inc.
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
237.8B USD | 13.9 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
771.5B USD | 72.8 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | -15 783.5 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
391.5B USD | 27.8 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2.3T DKK | 23.3 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
242.9B CHF | 21.1 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
186B GBP | 34.2 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
194.9B CHF | 18.5 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
158.2B USD | -54.1 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
145.1B USD | 18 |
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
132.4B EUR | 23.1 |
|
Earnings Growth | PEG | |||||
---|---|---|---|---|---|---|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
Average P/E:
28.1
13.9
|
17%
|
0.8 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
72.8
|
48%
|
1.5 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
Negative Multiple: -15 783.5 | N/A | N/A |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
27.8
|
26%
|
1.1 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
23.3
|
19%
|
1.2 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
21.1
|
16%
|
1.3 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
34.2
|
36%
|
1 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
18.5
|
16%
|
1.2 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
Negative Multiple: -54.1 | N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
18
|
29%
|
0.6 |
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
23.1
|
29%
|
0.8 |
|
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.